Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TESco Associates is a specialized contract development and manufacturing organization (CDMO) focused on bioabsorbable polymer technologies for the medical device industry. Founded in 1980 and headquartered in Tyngsborough, Massachusetts, the company provides a comprehensive range of services including material selection, research and development, and precision injection molding. They are globally recognized for their expertise in processing bioresorbable materials used in implants for orthopedics, cardiology, and drug delivery systems. In May 2021, TESco was acquired by Viant, a leading global medical device services provider, to enhance its capabilities in bioabsorbable technology. The company operates within ISO 13485 certified facilities and maintains state-of-the-art cleanroom environments for GMP manufacturing. TESco's engineering-first approach allows them to assist clients from the initial concept phase through to full-scale commercial production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TESco Associates.